Program

All times listed in the program are in Finnish time (UTC+2).

9:00 Onsite Registration Starts, Light Breakfast Available

9:30 Welcome to the Event!
Ouli Uimonen, CEO & Anja Isoaho, Training Manager, Pharmaca Health Intelligence
Moderator: Inka Heikkinen, Regulatory Policy Lead, Director, Lundbeck

09:40 Almost Two Years in! EU HTA Starting to Impact Reimbursement Processes Nationally
Niklas Hedberg, Chief Pharmacist, The Dental and Pharmaceuticals Benefits Agency (TLV, Sweden)

10:10 European Landscape: Progress and Perspectives
• Summary of Developments across EU Countries
• Experiences from the First Joint Clinical Assessments (JCAs)
• First National Procedures
Mihai Rotaru, Associate Director, Market Access, EFPIA

10:30 Individual Expert Input in the JCA Process: Initial Experiences from Patient and Clinician Involvement 
Julie Spony, Project Officer, European Commission, Directorate-General for Health and Food Safety

11:00 Break

11:20 Panel Discussion: EU HTA in Practice – First Experiences
Marlene Gyldmark, EU HTA Lead, BeOne Medicines
Mickael Lothgren, Vice President Global HEOR, Ipsen
Tuomas Oravilahti, Chief Specialist, Finnish Medicines Agency Fimea
Julie Spony, Project Officer, European Commission, Directorate-General for Health and Food Safety
Sian Tanner, Principal, Global Advisory Services, IQVIA

12:10 Lunch Break

13:10 How Has EU HTA Been Integrated in Sweden
Karolina Antonov, Head of Analysis, Lif – The Research-Based Pharmaceutical Industry in Sweden

13:40 From EU Assessment to National Reimbursement: Seamless Integration – Company and National HTA Agency Perspectives
Magnus Bangum, Interim Head of Market Access Norway, AbbVie
Tuomas Oravilahti, Chief Specialist, Finnish Medicines Agency Fimea
Outi Salminen, Senior Specialist, Council for Choices in Health Care in Finland
Anna Strömgren, Advisor EU HTA Regulation, The Dental and Pharmaceuticals Benefits Agency (TLV, Sweden)

14:30 Coffee Break

15:00 Panel Discussion: JCA Impact Nationally and Globally
Magnus Bangum, Interim Head of Market Access Norway, AbbVie
Mihai Rotaru, Associate Director, Market Access, EFPIA
Outi Salminen, Senior Specialist, Council for Choices in Health Care in Finland
Anna Strömgren, Advisor EU HTA Regulation, The Dental and Pharmaceuticals Benefits Agency (TLV, Sweden)

15:50–16:00 Closing Remarks
Inka Heikkinen, Regulatory Policy Lead, Director, Lundbeck
Anja Isoaho, Training Manager, Pharmaca Health Intelligence